Showing results (1711-1720 of 2,051) with videos related to

Sort By:
Pageof 206
Applied Optics|December 8, 2017
Fabrication of ultra-high numerical aperture GeO<sub>2</sub>-doped fiber and its use for broadband supercontinuum generationP Harshavardhan Reddy, A V Kir'yanov, Anirban Dhar, et al.
Stroke|April 17, 2020
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS TrialGeorge Ntaios, Lesly A Pearce, Roland Veltkamp, et al.
Frontiers in Pharmacology|April 6, 2023
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A reviewNem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Toxicology and Applied Pharmacology|January 24, 2024
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemiaVishal J Patel, Amit Joharapurkar, Samadhan G Kshirsagar, et al.
Electrophoresis|August 3, 2019
Analysis of thrombin-antithrombin complex formation using microchip electrophoresis and mass spectrometryJacob B Nielsen, Anna V Nielsen, Richard H Carson, et al.
Journal of Geriatric Oncology|April 19, 2022
Anal cancer in older adults: A Young International Society of Geriatric Oncology review paperBertha Alejandra Martinez-Cannon, Ana Cristina Torres Perez, Jacobo Hincapie-Echeverri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2017
B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic LipidsMunir Akkaya, Billur Akkaya, Pietro Miozzo, et al.
Human Pathology|July 5, 2014
Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significanceKosuke Miyai, Anna Kristiansen, Lars Egevad, et al.
Cardiovascular Endocrinology & Metabolism|May 14, 2023
Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysisRadhika Deshpande, Raj Patel, Manjari R Regmi, et al.
BMJ Open|January 9, 2025
Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trialErol Cimen, Kelvin Ng, Brian H Buck, et al.
Pageof 206